Velocity Clinical Research, Springdale ( Site 0112) — Cincinnati, Ohio

Velocity Clinical Research, Springdale ( Site 0112) is a clinical research site located in Cincinnati, Ohio, United States 45246.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Velocity Clinical Research, Springdale ( Site 0112) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Arteriosclerosis, Hypercholesterolaemia.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Velocity Clinical Research, Springdale ( Site 0112)?

Velocity Clinical Research, Springdale ( Site 0112) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Velocity Clinical Research, Springdale ( Site 0112) conducted?

Velocity Clinical Research, Springdale ( Site 0112) has 1 clinical trials on record, with 1 currently active. Their work covers Arteriosclerosis, Hypercholesterolaemia.

Is Velocity Clinical Research, Springdale ( Site 0112) accredited by Crixeo Health?

Velocity Clinical Research, Springdale ( Site 0112) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Velocity Clinical Research, Springdale ( Site 0112)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.